Drugs that contain Pegvisomant
1. Somavert patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5849535 | PHARMACIA | Human growth hormone variants |
Mar, 2017
(7 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6057292 | PHARMACIA | Method for inhibiting growth hormone action |
Sep, 2015
(8 years ago) | |
Market Authorisation Date: 31 July, 2014
Treatment: Acromegaly in patients w/inadequate response to surgery and/or radiation therapy and/or medical therapies, or for whom these therapies are not appropriate
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
SOMAVERT family patents
2. Somavert patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6057292 | PHARMACIA AND UPJOHN | Method for inhibiting growth hormone action |
Sep, 2015
(8 years ago) | |
| US5849535 | PHARMACIA AND UPJOHN | Human growth hormone variants |
Mar, 2017
(7 years ago) | |
Market Authorisation Date: 31 July, 2014
Treatment: Acromegaly in patients w/inadequate response to surgery and/or radiation therapy and/or medical therapies, or for whom these therapies are not appropriate
Dosage: INJECTABLE;SUBCUTANEOUS
More Information on Dosage
SOMAVERT family patents